esreboxetine has been researched along with Ache in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Dyck, B; Fleck, BA; Foster, AC; Grey, J; Jovic, F; Pick, R; Tamiya, J; Tran, JA; Vickers, T; Zhang, M | 1 |
| Chang, R; Church, TJ; Jaw-Tsai, S; Martin, WJ; Saito, DR; Smith, JA; Stangeland, EL; Van Dyke, PM; Van Orden, LJ | 1 |
| Arnold, LM; Ellis, A; Hirsch, I; Hughes, B; Sanders, P | 1 |
1 trial(s) available for esreboxetine and Ache
| Article | Year |
|---|---|
Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
Topics: Adult; Aged; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Morpholines; Pain; Pain Measurement; Patient Satisfaction; Severity of Illness Index; Treatment Outcome | 2012 |
2 other study(ies) available for esreboxetine and Ache
| Article | Year |
|---|---|
Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Membrane Transport Proteins; Models, Chemical; Neurotransmitter Agents; Neurotransmitter Transport Proteins; Norepinephrine; Pain; Rats; Structure-Activity Relationship | 2008 |
A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.
Topics: Animals; Crystallography, X-Ray; Disease Models, Animal; Humans; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pain; Pyrrolidines; Rats; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship | 2013 |